Search by Drug Name or NDC
NDC 00280-0020-01 Alka-Seltzer Plus Severe Cold PowerFast Fizz 325; 2; 7 mg/1; mg/1; mg/1 Details
Alka-Seltzer Plus Severe Cold PowerFast Fizz 325; 2; 7 mg/1; mg/1; mg/1
Alka-Seltzer Plus Severe Cold PowerFast Fizz is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Bayer HealthCare LLC.. The primary component is ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE.
Product Information
| NDC | 00280-0020 |
|---|---|
| Product ID | 0280-0020_030bc78e-6d7d-06cb-e063-6394a90afa70 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Alka-Seltzer Plus Severe Cold PowerFast Fizz |
| Proprietary Name Suffix | Orange Zest |
| Non-Proprietary Name | aspirin, chlorpheniramine maleate, phenylephrine bitartrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 325; 2; 7 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE |
| Labeler Name | Bayer HealthCare LLC. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor An |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00280-0020-01 (00280002001)
| NDC Package Code | 0280-0020-01 |
|---|---|
| Billing NDC | 00280002001 |
| Package | 10 POUCH in 1 CARTON (0280-0020-01) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2020-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |